Serum Ang 1, Ang 1–7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome
| dc.contributor.author | Gizem Çil | |
| dc.contributor.author | Ömer Araz | |
| dc.contributor.author | Buğra Kerget | |
| dc.contributor.author | Esra Laloglu | |
| dc.contributor.author | Alperen Aksakal | |
| dc.contributor.author | Elif Yılmazel Uçar | |
| dc.contributor.author | Leyla Sağlam | |
| dc.date.accessioned | 2025-07-08T06:10:13Z | |
| dc.date.available | 2025-07-08T06:10:13Z | |
| dc.date.issued | 2025-07 | |
| dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | |
| dc.description.abstract | AimsIn obstructive sleep apnea (OSA), the balance between inflammatory and anti-inflammatory responses is disrupted. This study examined the association between serum angiotensin 1 (Ang 1), angiotensin 1-7 (Ang 1-7), and Mas receptor levels and OSA severity. Material and methodsA total of 190 subjects underwent polysomnography and serum analysis for Ang 1, Ang 1-7, and Mas using ELISA. Patients were classified into control, mild, moderate, and severe OSA groups based on AHI. ResultsAng 1-7, Ang 1, and serum Mas levels were significantly lower in moderate and severe OSA groups compared to control and mild OSA (p < 0.001). Negative correlations were found between these biomarkers and AHI (e.g. Ang 1-7: R = -0.597, p < 0.001). ROC analysis showed strong diagnostic performance: AUC was 0.864 for Ang 1-7, 0.873 for Ang 1, and 0.837 for Mas, with sensitivity of 98%, 98%, and 97%, respectively. ConclusionReduced levels of Ang 1-7, Ang 1, and Mas are associated with increased OSA severity. These biomarkers demonstrated high diagnostic value and may be useful in stratifying patients with moderate-to-severe OSA. | |
| dc.identifier.citation | Çil, G., Araz, Ö., Kerget, B., Laloglu, E., Aksakal, A., Yılmazel Uçar, E., & Sağlam, L. (2025). Serum Ang 1, Ang 1–7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome. Biomarkers in Medicine, 1-9. | |
| dc.identifier.doi | 10.1080/17520363.2025.2525059 | |
| dc.identifier.issn | 1752-0363 | |
| dc.identifier.issn | 1752-0371 | |
| dc.identifier.pmid | 40590829 | |
| dc.identifier.uri | https://doi.org/10.1080/17520363.2025.2525059 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12604/8754 | |
| dc.identifier.wos | WOS:001521072500001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | PubMed | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Çil, Gizem | |
| dc.language.iso | en | |
| dc.publisher | Informa UK Limited | |
| dc.relation.ispartof | Biomarkers in Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Ang 1-4 | |
| dc.subject | Mas | |
| dc.subject | RAAS | |
| dc.subject | obstructive sleep apnea syndrome | |
| dc.subject | polysomnography. | |
| dc.title | Serum Ang 1, Ang 1–7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome | |
| dc.type | Article |
Dosyalar
Lisans paketi
1 - 1 / 1
Yükleniyor...
- İsim:
- license.txt
- Boyut:
- 1,17 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:











